Shana K. Cyr, PhD

Shana K. Cyr, PhD, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. Dr. Cyr focuses on complex patent disputes related to pharmaceuticals, biologics, combination products, and diagnostics. Her experience includes traditional patent litigation, Hatch-Waxman litigation related to abbreviated new drug applications and 505(b)(2) applications, proceedings before the International Trade Commission, inter partes reviews, inter partes reexaminations, interferences, and appeals to the US Court of Appeals for the Federal Circuit. Dr. Cyr also counsels clients on issues at the intersection of patent and FDA law.